| TERTIARY STRUCTURE DATA |
|
hepatitis C virus
|
| mature peptidase |
2.50 Å |
2A4G |
2A4G |
2A4G |
2A4G |
2A4G |
2A4G |
Arasappan et al., 2005 |
| mature peptidase |
2.50 Å |
2GVF |
2GVF |
2GVF |
2GVF |
2GVF |
2GVF |
Arasappan et al., 2006 |
| catalytic domain of the NS2 protein only |
2.28 Å |
2HD0 |
2HD0 |
2HD0 |
2HD0 |
2HD0 |
2HD0 |
Lorenz et al., 2006 |
| mature peptidase |
1.55 Å |
3HKW |
3HKW |
3HKW |
3HKW |
3HKW |
3HKW |
Nyanguile et al., 2010 |
| mature peptidase |
2.30 Å |
3KN2 |
3KN2 |
3KN2 |
3KN2 |
3KN2 |
3KN2 |
Nair et al., 2010 |
| avoiding drug resistance against hcv ns3/4a protease inhibitors |
1.70 Å |
3M5M |
3M5M |
3M5M |
3M5M |
3M5M |
3M5M |
|
| visualizing atp-dependent rna translocation by the ns3 helicase from hcv |
1.95 Å |
3O8B |
3O8B |
3O8B |
3O8B |
3O8B |
3O8B |
|
| visualizing atp-dependent rna translocation by the ns3 helicase from hcv |
2.00 Å |
3O8C |
3O8C |
3O8C |
3O8C |
3O8C |
3O8C |
|
| visualizing atp-dependent rna translocation by the ns3 helicase from hcv |
2.05 Å |
3O8D |
3O8D |
3O8D |
3O8D |
3O8D |
3O8D |
|
| visualizing atp-dependent rna translocation by the ns3 helicase from hcv |
2.30 Å |
3O8R |
3O8R |
3O8R |
3O8R |
3O8R |
3O8R |
|
| mature peptidase |
2.14 Å |
3QGH |
3QGH |
3QGH |
3QGH |
3QGH |
3QGH |
Gentles et al., 2011 |
| mature peptidase |
1.80 Å |
3QGI |
3QGI |
3QGI |
3QGI |
3QGI |
3QGI |
Gentles et al., 2011 |
| mature peptidase |
1.50 Å |
3RC4 |
3RC4 |
3RC4 |
3RC4 |
3RC4 |
3RC4 |
Romano et al., 2011 |
| mature peptidase |
1.60 Å |
3RC5 |
3RC5 |
3RC5 |
3RC5 |
3RC5 |
3RC5 |
Romano et al., 2011 |
| crystal structure of hepatitis c virus ns3 helicase inhibitor co- complex with fragment 1 [(5-bromo-1h-indol-3-yl)acetic acid] |
2.25 Å |
4OJQ |
4OJQ |
4OJQ |
4OJQ |
4OJQ |
4OJQ |
|
| crystal structure of hepatitis c virus ns3 helicase inhibitor co- complex with compound 7 [[1-(3-chlorobenzyl)-1h-indol-3-yl]acetic acid] |
2.30 Å |
4OK3 |
4OK3 |
4OK3 |
4OK3 |
4OK3 |
4OK3 |
|
| crystal structure of hepatitis c virus ns3 helicase inhibitor co- complex with compound 9 [1-(3-ethynylbenzyl)-1h-indol-3-yl]acetic acid] |
2.15 Å |
4OK5 |
4OK5 |
4OK5 |
4OK5 |
4OK5 |
4OK5 |
|
| crystal structure of hepatitis c virus ns3 helicase inhibitor co- complex with compound 13 [[1-(2-methoxy-5-nitrobenzyl)-1h-indol-3- yl]acetic acid] |
2.40 Å |
4OK6 |
4OK6 |
4OK6 |
4OK6 |
4OK6 |
4OK6 |
|
| crystal structure of hepatitis c virus ns3 helicase inhibitor co- complex with compound 19 [[6-(3,5-diaminophenyl)-1-(2-methoxy-5- nitrobenzyl)-1h-indol-3-yl]acetic acid] |
2.25 Å |
4OKS |
4OKS |
4OKS |
4OKS |
4OKS |
4OKS |
|